Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-10-2016 | Head and Neck

Predictors of post-treatment smoking and drinking behavior of head and neck cancer survivors: results of a population-based survey

Authors: Ulrike Schiller, Johanna Inhestern, Ulrike Burger, Susanne Singer, Orlando Guntinas-Lichius

Published in: European Archives of Oto-Rhino-Laryngology | Issue 10/2016

Abstract

Predictors for smoking and alcohol drinking behavior were investigated in head and neck cancer survivors (HNCS) with survivorship of ≥6 months. 165 HNCS registered in a regional cancer registry and treated 2005–2014 were included. Patients completed a survey including the Fagerström Test for nicotine dependence and the Alcohol Use Disorders Identification Test. Smoking and drinking cessation rates were 51 and 13 %, respectively. Multinomial logistic regression analyses showed that male patients [odds ratio (OR) 35.4; confidence interval (CI) 7.5–168.1; p < 0.0001], single persons (OR 9.9; CI 2.5–40.0; p = 0.001), and younger patients (OR 1.1; CI 1.0–1.1; p = 0.002) had significantly higher probability to be current smokers. Male gender (OR 48.7; CI 5.0–470.7; p < 0.0001) and younger age (OR 1.1; CI 1.0–1.3; p = 0.003) were predictors of risky alcohol consumption. Male, young, and single smoking and/or drinking HNCS should be stimulated to take part in smoking and/or alcohol drinking cessation programs.

Available only for authorised users

Blot WJ, McLaughlin JK, Winn DM et al (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48(11):3282–3287PubMed

Mashberg A, Boffetta P, Winkelman R, Garfinkel L (1993) Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 72(4):1369–1375CrossRefPubMed

Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. New Engl J Med 363(1):24–35CrossRefPubMedPubMedCentral

Carter BD, Abnet CC, Feskanich D et al (2015) Smoking and mortality—beyond established causes. New Engl J Med 372(7):631–640CrossRefPubMed

Browman GP, Wong G, Hodson I et al (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. New Engl J Med 328(3):159–163CrossRefPubMed

Gillison ML, Zhang Q, Jordan R et al (2012) Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 30(17):2102–2111CrossRefPubMedPubMedCentral

O’Shea R, Byrne H, Tuckett J, O’Leary G, Sheahan P (2015) Impact of current smoking and alcohol consumption on gastrostomy duration in patients with head and neck cancer undergoing definitive chemoradiotherapy. Otolaryngol Head Neck Surg 141(5):463–469CrossRef

Lee DH, Roh JL, Baek S et al (2013) Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 149(4):579–586CrossRefPubMed

Gan SJ, Dahlstrom KR, Peck BW et al (2013) Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer 119(14):2593–2601CrossRefPubMedPubMedCentral

10.

Deleyiannis FW, Thomas DB, Vaughan TL, Davis S (1996) Alcoholism: independent predictor of survival in patients with head and neck cancer. J Nat Cancer Inst 88(8):542–549CrossRefPubMed

11.

Lambert MT, Terrell JE, Copeland LA, Ronis DL, Duffy SA (2005) Cigarettes, alcohol, and depression: characterizing head and neck cancer survivors in two systems of care. Nicotine Tob Res 7(2):233–241CrossRefPubMed

12.

Potash AE, Karnell LH, Christensen AJ, Vander Weg MW, Funk GF (2010) Continued alcohol use in patients with head and neck cancer. Head Neck 32(7):905–912PubMed

13.

Sharp L, Johansson H, Fagerstrom K, Rutqvist LE (2008) Smoking cessation among patients with head and neck cancer: cancer as a ‘teachable moment’. Eur J Cancer Care 17(2):114–119CrossRef

14.

Duffy SA, Khan MJ, Ronis DL et al (2008) Health behaviors of head and neck cancer patients the first year after diagnosis. Head Neck 30(1):93–102CrossRefPubMed

15.

Simmons VN, Litvin EB, Jacobsen PB et al (2013) Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer 119(7):1420–1427CrossRefPubMed

16.

Narwani V, Harries M (2014) Treatment modality: a predictor of continued tobacco use after treatment in patients with laryngeal cancer. J Laryngol Otol 128(2):153–158CrossRefPubMed

17.

Genther DJ, Gourin CG (2012) The effect of alcohol abuse and alcohol withdrawal on short-term outcomes and cost of care after head and neck cancer surgery. Laryngoscope 122(8):1739–1747CrossRefPubMed

18.

D’Hoore W, Sicotte C, Tilquin C (1993) Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 32(5):382–387PubMed

19.

Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 86(9):1119–1127CrossRefPubMed

20.

Gritz ER, Carr CR, Rapkin DA, Chang C, Beumer J, Ward PH (1991) A smoking cessation intervention for head and neck cancer patients: trial design, patient accrual, and characteristics. Cancer Epidemiol Biomark Prev 1(1):67–73

21.

Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 88(6):791–804CrossRefPubMed

22.

Duffy SA, Ronis DL, Valenstein M et al (2007) Depressive symptoms, smoking, drinking, and quality of life among head and neck cancer patients. Psychosomatics 48(2):142–148CrossRefPubMed

23.

Giovino GA, Mirza SA, Samet JM et al (2012) Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 380(9842):668–679CrossRefPubMed

24.

Shield KD, Rylett M, Gmel G, Gmel G, Kehoe-Chan TA, Rehm J (2013) Global alcohol exposure estimates by country, territory and region for 2005—a contribution to the comparative risk assessment for the 2010 global burden of disease study. Addiction 108(5):912–922CrossRefPubMed

25.

Bilano V, Gilmour S, Moffiet T et al (2015) Global trends and projections for tobacco use, 1990–2025: an analysis of smoking indicators from the WHO comprehensive information systems for tobacco control. Lancet 385(9972):966–976CrossRefPubMed

26.

Hapke U, von der Lippe E, Gaertner B (2013) Alcohol consumption, at-risk and heavy episodic drinking with consideration of injuries and alcohol-specific medical advice: results of the German health interview and examination survey for adults (DEGS1). Bundesgesundh Gesundh Gesundh 56(5–6):809–813CrossRef

27.

Lee YC, Zugna D, Richiardi L et al (2013) Smoking addiction and the risk of upper-aerodigestive-tract cancer in a multicenter case–control study. Int J Cancer 133(11):2688–2695PubMed

28.

Gritz ER, Schacherer C, Koehly L, Nielsen IR, Abemayor E (1999) Smoking withdrawal and relapse in head and neck cancer patients. Head Neck 21(5):420–427CrossRefPubMed

29.

Christensen AJ, Moran PJ, Ehlers SL, Raichle K, Karnell L, Funk G (1999) Smoking and drinking behavior in patients with head and neck cancer: effects of behavioral self-blame and perceived control. J Behav Med 22(5):407–418CrossRefPubMed

30.

Singer S, Keszte J, Thiele A et al (2010) Smoking behaviour after laryngectomy. Laryngo Rhino Otol 89(3):146–150CrossRef

31.

Sivasithamparam J, Visk CA, Cohen EE, King AC (2013) Modifiable risk behaviors in patients with head and neck cancer. Cancer 119(13):2419–2426CrossRefPubMedPubMedCentral

32.

Ostroff JS, Jacobsen PB, Moadel AB et al (1995) Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer 75(2):569–576CrossRefPubMed

33.

Danker H, Keszte J, Singer S et al (2011) Alcohol consumption after laryngectomy. Clin Otolaryngol 36(4):336–344CrossRefPubMed

34.

Gritz ER, Carr CR, Rapkin D et al (1993) Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomark Prev 2(3):261–270

35.

Duffy SA, Scheumann AL, Fowler KE, Darling-Fisher C, Terrell JE (2010) Perceived difficulty quitting predicts enrollment in a smoking-cessation program for patients with head and neck cancer. Oncol Nurs Forum 37(3):349–356CrossRefPubMedPubMedCentral

36.

Hatcher JL, Sterba KR, Tooze JA et al (2014) Tobacco use and surgical outcomes in patients with head and neck cancer. Head Neck. doi: 10.1002/hed.23944. (Epub ahead of print)

37.

Kroke A, Klipstein-Grobusch K, Hoffmann K, Terbeck I, Boeing H, Helander A (2001) Comparison of self-reported alcohol intake with the urinary excretion of 5-hydroxytryptophol:5-hydroxyindole-3-acetic acid, a biomarker of recent alcohol intake. Br J Nutr 85(5):621–627CrossRefPubMed

Title: Predictors of post-treatment smoking and drinking behavior of head and neck cancer survivors: results of a population-based survey
Authors: Ulrike Schiller
Johanna Inhestern
Ulrike Burger
Susanne Singer
Orlando Guntinas-Lichius
Publication date: 01-10-2016
Publisher: Springer Berlin Heidelberg
Published in: European Archives of Oto-Rhino-Laryngology / Issue 10/2016
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-016-3924-6

At a glance: The STEP trials

Springer Medicine

Predictors of post-treatment smoking and drinking behavior of head and neck cancer survivors: results of a population-based survey

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2016

Association between sleep quality and psychiatric disorders in patients with subjective tinnitus in China

Pathologic features of metastatic lymph nodes identified from prophylactic central neck dissection in patients with papillary thyroid carcinoma

Cross-cultural validation of a taste test with paper strips

Optimal time for intranasal splint removal after septoplasty: a prospective clinical study

Granular cell tumor in two oral anatomic sites

Bone-anchored hearing aids in conductive and mixed hearing losses: why do patients reject them?